Wirtschaftsnachrichten (Symbolbild).
Dienstag, 04.08.2015 15:15 von | Aufrufe: 151

Regis Foundation for Breast Cancer Research Donates $800,000 to Two Leading Research Centers

Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

MINNEAPOLIS, Aug. 4, 2015 /PRNewswire/ -- Regis Corporation (NYSE:RGS), a leader in beauty salons and cosmetology education with brands including Supercuts, SmartStyle and Regis Salons, is pleased to announce that its foundation, the Regis Foundation for Breast Cancer Research, recently made a combined donation of $800,000 to two leading research centers in an ongoing effort to support the fight against breast cancer. The foundation donated $400,000 to Mayo Clinic and $400,000 to the Masonic Cancer Center, University of Minnesota.

Regis Corporation.

"Breast cancer touches the lives of many of our guests, stylists, team members, friends and families, so we are proud to continue funding groundbreaking research to fight this devastating disease," said Dan Hanrahan, president and CEO of Regis Corporation. "Regis believes in supporting Mayo Clinic and the Masonic Cancer Center, University of Minnesota, both of which have tremendous research programs that work to find a cure for breast cancer."

Mayo Clinic. For Mayo Clinic, the Regis Foundation contribution will support the Breast Cancer Genome-Guided Therapy (BEAUTY), or Project BEAUTY. It will fund Part 2 of Project BEAUTY, which will allow researchers to focus on the toughest breast cancer cases by sequencing tumors at a crucial point —following 18 to 20 weeks of treatment, when cancer has either been eradicated or developed resistance to chemotherapy. The Project BEAUTY study is designed to help researchers and physicians better understand why current standard chemotherapy eradicates breast cancer in some women but fails in others.

Project BEAUTY is part of the Mayo Clinic Center for Individualized Medicine, home to the Individualized Medicine Clinic, the world's first integrated, multidisciplinary genomics clinic, serving patients with advanced cancer and diagnostic dilemmas. The center discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient.

Masonic Cancer Center, University of Minnesota. With the Masonic Cancer Center, University of Minnesota, the Regis Foundation will be supporting four innovative initiatives: I-SPY clinical trials that test new treatments in less time and for a fraction of the cost; the development of new hormonal therapies, the sensitive detection of breast cancer metastasis by MRIs, and the sensitive detection of bone loss during breast cancer therapy.

The Masonic Cancer Center, University of Minnesota creates a collaborative research environment focused on the causes, prevention, detection and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals and the community.

Regis Corporation has supported breast cancer research since 1990, raising more than $11 million for its foundation. Every October, which is Breast Cancer Awareness month, Regis Corporation salons, stylists, guests and business partners come together during the company's annual Clip for the Cure campaign to raise money for breast cancer research. The campaign's highlight includes a daylong haircutting event where stylists at nearly 7,000 salons throughout the country give haircuts to over 220,000 guests, with a portion of proceeds going to the Regis Foundation for Breast Cancer Research. In addition, guests help raise funds by purchasing limited edition "pink" products and donating to the cause throughout the campaign.

ARIVA.DE Börsen-Geflüster


Over 30 Regis Corporation salon brands participated in the 2014 Clip for the Cure campaign.  For more information, visit www.ClipForTheCure.org.

The Regis Foundation for Breast Cancer Research
The Regis Foundation for Breast Cancer Research funds groundbreaking research at nationally recognized centers. The focus of this research is on prevention, early diagnosis, treatment and finding a cure. In addition, the Foundation supports institutions that assist and treat patients with breast cancer. Since it was founded in 1994, the Foundation has raised over $11 million.

About Regis Corporation
Regis Corporation (NYSE:RGS) is the leader in beauty salons and cosmetology education. As of March 31, 2015, the Company owned, franchised or held ownership interests in 9,567 worldwide locations. Regis' corporate and franchised locations operate under concepts such as Supercuts, SmartStyle, MasterCuts, Regis Salons, Sassoon Salon, Cost Cutters and First Choice Haircutters. Regis maintains ownership interests in Empire Education Group in the U.S. and the MY Style concepts in Japan. For additional information about the Company, including a reconciliation of certain non-GAAP financial information and certain supplemental financial information, please visit the Investor Information section of the corporate website at www.RegisCorp.com.

Logo - http://photos.prnewswire.com/prnh/20130912/CG78396LOGO 


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regis-foundation-for-breast-cancer-research-donates-800000-to-two-leading-research-centers-300122869.html

SOURCE Regis Corporation


Mehr Nachrichten zur Regis Corp (Minneapolis) Aktie kostenlos abonnieren

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.